Sobi has a long history of collaboration with partners in all phases of the product life cycle, from early research and development through commercialization.
Today the company has about 40 partners, most of them related to licensing- or distribution agreements regarding products. Sobi also has a valuable partnership related to the late-stage hemophilia programs and a number of contract manufacturers for the production of drug substance.
We have capabilities from preclinical and clinical development of biologics, as well as in protein manufacturing and process scale-up.
Other key competitive advantages as a partner include an integrated marketing and sales force and a medical affairs and market access infrastructure. Read more about our capabilities under Operations.
What are we looking for?
Sobi is continuously searching for product opportunities with a high degree of innovation, fulfilling unmet medical needs in a niche specialty setting for distribution or in-licensing as well as acquisition.
Sobi is committed to making our medicines available to the rare disease patients all across the world. We cover geographical Europe through our own organization and have recently established a subsidiary in the US. We have additional dedicated distributors and partners that market our products in Middle East, Australia and New Zealand.
Sobi Partner Products
Our Partner Products business line offers small and mid-sized pharmaceutical and biotech companies an integrated solution for commercialization of their products, mainly in the Nordic region where it is the market leader.
We are open to evaluate opportunities in all stages of a products life cycle. If you are interested in contacting Sobi, please send an email to our corporate development team.